Parent Drug and Active Metabolite (FDA) [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2006-05-10 10:22 (7329 d 23:57 ago) – Posting: # 123
Views: 11,665

❝ […] would this mean that ANOVA on the metabolite data is not necessary?


Hi Joy,

yes, IMHO no confidence interval of the metabolite; you should present just means, standard deviations, etc. If you opt to present a confidence interval make clear in the protocol, that there's no acceptance range for it.

The wonderful thing about FDA is that you have to present the study protocol to them anyhow; if they don't like it, they will tell you ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
218 visitors (0 registered, 218 guests [including 25 identified bots]).
Forum time: 10:19 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5